A four-year-old has become the first person in the UK enrolled on an innovative gene therapy to treat his muscular dystrophy.
Charlie has travelled to the John Walton Muscular Dystrophy Research Centre (JWMDRC) in Newcastle all the way from Aberdeen. He has Duchenne muscular dystrophy - a severe genetic disease which cases muscle wastage and leads to gradual loss of mobility.
Those with the condition are only expected to live into their early 20s. The JWMDRC - a world-leading research unit run by Newcastle University and the Newcastle Hospitals NHS Trust - is carrying a trial called EMBARK which is studying how gene therapy can combat the condition.
